Genetically predicted glucose-dependent insulinotropic polypeptide (GIP) levels and cardiovascular disease risk are driven by distinct causal variants in the GIPR region
Inflammatory Markers: Include CRP and homocysteine to measure systemic inflammation levels
Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: the PIONEER programme
"You can't think you can get on a GLP-1 medication and it's going to completely change everything," says Madison
In addition to effective and sustained weight loss, many patients experience improved health markers, including lower blood sugar levels, better blood pressure, and healthier cholesterol numbers
Customers expecting rapid weight loss may be disappointed, which contributes to some negative reviews